Finally, accumulated evidence demonstrates that elevated IL‐1β, IL‐6, and TNFα levels are associated with either tumor stage, survival rate, or distant metastasis in CRC patients 1, 11, 12. This evidence concerns the gene IL1B and colorectal carcinoma.